The epilepsy treatment gap

The ILAE Commission on the Developing World has defined the epilepsy treatment gap as the difference between the number of people with epilepsy and those who actually receive antiseizure medication.¹ In a systematic review of 45 epidemiological studies, the estimated epilepsy treatment gap increased from 9.8% in HICs to 86.9% in LICs.¹

Reference:

1.Kwon C-S, Wagner RG, Carpio A, et al. The worldwide epilepsy treatment gap: A systematic review and recommendations for revised definitions – A report from the ILAE Epidemiology Commission. Epilepsia 2022; 63 (3): 551–564.